|
Diabetes, Vol 44, Issue 8 936-946, Copyright © 1995 by American Diabetes Association
Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures
RR Henry, L Abrams, S Nikoulina and TP Ciaraldi
Department of Medicine, University of California, San Diego, La Jolla, USA.
Myoblasts from human skeletal muscle were isolated from needle biopsy
samples of vastus lateralis and fused to differentiated multinucleated
myotubes. Specific high-affinity insulin and insulin-like growth factor I
(IGF-I) binding, glucose transporter proteins GLUT1 and GLUT4, glycogen
synthase and pyruvate dehydrogenase proteins, and their specific mRNAs were
identified in fused myotubes. Insulin and IGF-I stimulated 2-deoxyglucose
uptake twofold with half-maximal stimulation by insulin at 0.98 +/- 0.12
nmol/l and maximal stimulation at 17.5 nmol/l. Acute insulin treatment (33
nmol/l) doubled glycogen synthase activity and glucose incorporation into
glycogen while increasing pyruvate dehydrogenase approximately 30%. In
cells cultured from NIDDM subjects, both basal (6.9 +/- 1.0 vs. 13.0 +/-
1.7 pmol.mg protein-1.min-1) and acute insulin-stimulated transport (13.5
+/- 2.0 vs. 22.4 +/- 1.3 pmol.mg protein-1.min-1) were significantly
reduced compared with nondiabetic control subjects (both P < or =
0.005). GLUT1 protein content of total membranes from NIDDM subjects was
decreased compared with control subjects, while GLUT4 levels were similar
between groups. A significant correlation (r = 0.65, P < or = 0.05) was
present when maximal rates of insulin-stimulated glucose transport in cell
culture from subjects were compared with their corresponding in vivo
glucose disposal determined by hyperinsulinemic glucose clamp. In summary,
differentiated human skeletal muscle cultures exhibit biochemical and
molecular features of insulin-stimulated glucose transport and
intracellular enzyme activity comparable with the in vivo situation.
Defective insulin-stimulated glucose transport persists in muscle cultures
from NIDDM subjects and resembles the reduced insulin-mediated glucose
uptake present in vivo. We conclude that this technique provides a relevant
cellular model to study insulin action and glucose metabolism in normal
subjects and determine the mechanisms of insulin resistance in NIDDM.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Reyna, S. Ghosh, P. Tantiwong, C.S. R. Meka, P. Eagan, C. P. Jenkinson, E. Cersosimo, R. A. DeFronzo, D. K. Coletta, A. Sriwijitkamol, et al.
Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects
Diabetes,
October 1, 2008;
57(10):
2595 - 2602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Q. Wang, W. T. Cefalu, X. H. Zhang, Y. Yu, J. Qin, L. Son, P. M. Rogers, N. Mashtalir, J. R. Bordelon, J. Ye, et al.
Human Adenovirus Type 36 Enhances Glucose Uptake in Diabetic and Nondiabetic Human Skeletal Muscle Cells Independent of Insulin Signaling
Diabetes,
July 1, 2008;
57(7):
1805 - 1813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Ciaraldi, S. E. Nikoulina, R. A. Bandukwala, L. Carter, and R. R. Henry
Role of Glycogen Synthase Kinase-3{alpha} in Insulin Action in Cultured Human Skeletal Muscle Cells
Endocrinology,
September 1, 2007;
148(9):
4393 - 4399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Wensaas, A. C. Rustan, K. Lovstedt, B. Kull, S. Wikstrom, C. A. Drevon, and S. Hallen
Cell-based multiwell assays for the detection of substrate accumulation and oxidation
J. Lipid Res.,
April 1, 2007;
48(4):
961 - 967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaster
Metabolic flexibility is conserved in diabetic myotubes
J. Lipid Res.,
January 1, 2007;
48(1):
207 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pendergrass, A. Bertoldo, R. Bonadonna, G. Nucci, L. Mandarino, C. Cobelli, and R. A. DeFronzo
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals
Am J Physiol Endocrinol Metab,
January 1, 2007;
292(1):
E92 - E100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. K.R. Karlsson, M. Ahlsen, J. R. Zierath, H. Wallberg-Henriksson, and H. A. Koistinen
Insulin signaling and glucose transport in skeletal muscle from first-degree relatives of type 2 diabetic patients.
Diabetes,
May 1, 2006;
55(5):
1283 - 1288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Corbould, H. Zhao, S. Mirzoeva, F. Aird, and A. Dunaif
Enhanced Mitogenic Signaling in Skeletal Muscle of Women With Polycystic Ovary Syndrome
Diabetes,
March 1, 2006;
55(3):
751 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Aas, M. H. Rokling-Andersen, E. T. Kase, G. H. Thoresen, and A. C. Rustan
Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells
J. Lipid Res.,
February 1, 2006;
47(2):
366 - 374.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Ciaraldi, S. A. Phillips, L. Carter, V. Aroda, S. Mudaliar, and R. R. Henry
Effects of the Rapid-Acting Insulin Analog Glulisine on Cultured Human Skeletal Muscle Cells: Comparisons with Insulin and Insulin-Like Growth Factor I
J. Clin. Endocrinol. Metab.,
October 1, 2005;
90(10):
5551 - 5558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR{gamma} agonists
Am J Physiol Endocrinol Metab,
July 1, 2005;
289(1):
E151 - E159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Corbould, Y.-B. Kim, J. F. Youngren, C. Pender, B. B. Kahn, A. Lee, and A. Dunaif
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
Am J Physiol Endocrinol Metab,
May 1, 2005;
288(5):
E1047 - E1054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Ciaraldi, S. Mudaliar, A. Barzin, J. A. Macievic, S. V. Edelman, K. S. Park, and R. R. Henry
Skeletal Muscle GLUT1 Transporter Protein Expression and Basal Leg Glucose Uptake Are Reduced in Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
January 1, 2005;
90(1):
352 - 358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Al-Khalili, A. Krook, J. R. Zierath, and G. D. Cartee
Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake
Am J Physiol Endocrinol Metab,
September 1, 2004;
287(3):
E553 - E557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. McIntyre, R. Halse, S. J. Yeaman, and M. Walker
Cultured Muscle Cells from Insulin-Resistant Type 2 Diabetes Patients Have Impaired Insulin, but Normal 5-Amino-4-Imidazolecarboxamide Riboside-Stimulated, Glucose Uptake
J. Clin. Endocrinol. Metab.,
July 1, 2004;
89(7):
3440 - 3448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaster, A. C. Rustan, V. Aas, and H. Beck-Nielsen
Reduced Lipid Oxidation in Skeletal Muscle From Type 2 Diabetic Subjects May Be of Genetic Origin: Evidence From Cultured Myotubes
Diabetes,
March 1, 2004;
53(3):
542 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gosmain, E. Lefai, S. Ryser, M. Roques, and H. Vidal
Sterol Regulatory Element-Binding Protein-1 Mediates the Effect of Insulin on Hexokinase II Gene Expression in Human Muscle Cells
Diabetes,
February 1, 2004;
53(2):
321 - 329.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. M. Wilmsen, T. P. Ciaraldi, L. Carter, N. Reehman, S. R. Mudaliar, and R. R. Henry
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects
Am J Physiol Endocrinol Metab,
August 1, 2003;
285(2):
E354 - E362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Bouzakri, M. Roques, P. Gual, S. Espinosa, F. Guebre-Egziabher, J.-P. Riou, M. Laville, Y. Le Marchand-Brustel, J.-F. Tanti, and H. Vidal
Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes
Diabetes,
June 1, 2003;
52(6):
1319 - 1325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan
Blood flow and muscle metabolism: a focus on insulin action
Am J Physiol Endocrinol Metab,
February 1, 2003;
284(2):
E241 - E258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Haupt, C. Kausch, D. Dahl, O. Bachmann, M. Stumvoll, H.-U. Haring, and S. Matthaei
Effect of Glimepiride on Insulin-Stimulated Glycogen Synthesis in Cultured Human Skeletal Muscle Cells: A comparison to glibenclamide
Diabetes Care,
December 1, 2002;
25(12):
2129 - 2132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Nikoulina, T. P. Ciaraldi, S. Mudaliar, L. Carter, K. Johnson, and R. R. Henry
Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle
Diabetes,
July 1, 2002;
51(7):
2190 - 2198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaster, I. Petersen, K. Hojlund, P. Poulsen, and H. Beck-Nielsen
The Diabetic Phenotype Is Conserved in Myotubes Established From Diabetic Subjects: Evidence for Primary Defects in Glucose Transport and Glycogen Synthase Activity
Diabetes,
April 1, 2002;
51(4):
921 - 927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Vollenweider, B. Menard, and P. Nicod
Insulin Resistance, Defective Insulin Receptor Substrate 2--Associated Phosphatidylinositol-3' Kinase Activation, and Impaired Atypical Protein Kinase C ({zeta}/{lambda}) Activation in Myotubes From Obese Patients With Impaired Glucose Tolerance
Diabetes,
April 1, 2002;
51(4):
1052 - 1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. G. Wahl, C. Kausch, F. Machicao, K. Rett, M. Stumvoll, and H.-U. Haring
Troglitazone Downregulates {Delta}-6 Desaturase Gene Expression in Human Skeletal Muscle Cell Cultures
Diabetes,
April 1, 2002;
51(4):
1060 - 1065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I.W. Phillips, and C. D. Byrne
Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome
Diabetes,
April 1, 2002;
51(4):
1066 - 1075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Nikoulina, T. P. Ciaraldi, L. Carter, S. Mudaliar, K. S. Park, and R. R. Henry
Impaired Muscle Glycogen Synthase in Type 2 Diabetes Is Associated with Diminished Phosphatidylinositol 3-Kinase Activation
J. Clin. Endocrinol. Metab.,
September 1, 2001;
86(9):
4307 - 4314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Perriott, T. Kono, R. R. Whitesell, S. M. Knobel, D. W. Piston, D. K. Granner, A. C. Powers, and J. M. May
Glucose uptake and metabolism by cultured human skeletal muscle cells: rate-limiting steps
Am J Physiol Endocrinol Metab,
July 1, 2001;
281(1):
E72 - E80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaster, J. Franch, P. Staehr, H. Beck-Nielsen, T. Smith, and H. D. Schroder
Induction of GLUT-1 protein in adult human skeletal muscle fibers
Am J Physiol Endocrinol Metab,
November 1, 2000;
279(5):
E1191 - E1195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gaster, A. Handberg, H. Beck-Nielsen, and H. D. Schroder
Glucose transporter expression in human skeletal muscle fibers
Am J Physiol Endocrinol Metab,
September 1, 2000;
279(3):
E529 - E538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Mott, C. Hoyt, R. Caspari, K. Stone, R. Pratley, and C. Bogardus
Palmitate oxidation rate and action on glycogen synthase in myoblasts from insulin-resistant subjects
Am J Physiol Endocrinol Metab,
September 1, 2000;
279(3):
E561 - E569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Chalfant, T. P. Ciaraldi, J. E. Watson, S. Nikoulina, R. R. Henry, and D. R. Cooper
Protein Kinase C{theta} Expression Is Increased upon Differentiation of Human Skeletal Muscle Cells: Dysregulation in Type 2 Diabetic Patients and a Possible Role for Protein Kinase C{theta} in Insulin-Stimulated Glycogen Synthase Activity
Endocrinology,
August 1, 2000;
141(8):
2773 - 2778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Roques and H. Vidal
A Phosphatidylinositol 3-Kinase/p70 Ribosomal S6 Protein Kinase Pathway Is Required for the Regulation by Insulin of the p85alpha Regulatory Subunit of Phosphatidylinositol 3-Kinase Gene Expression in Human Muscle Cells
J. Biol. Chem.,
November 26, 1999;
274(48):
34005 - 34010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-B. Book and A. Dunaif
Selective Insulin Resistance in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab.,
September 1, 1999;
84(9):
3110 - 3116.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. P. Ciaraldi, L. Carter, S. Nikoulina, S. Mudaliar, D. A. McClain, and R. R. Henry
Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects
Endocrinology,
September 1, 1999;
140(9):
3971 - 3980.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Furling, A. Marette, and J. Puymirat
Insulin-Like Growth Factor I Circumvents Defective Insulin Action in Human Myotonic Dystrophy Skeletal Muscle Cells
Endocrinology,
September 1, 1999;
140(9):
4244 - 4250.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. F. Youngren, I. D. Goldfine, and R. E. Pratley
Insulin receptor autophosphorylation in cultured myoblasts correlates to glucose disposal in Pima Indians
Am J Physiol Endocrinol Metab,
May 1, 1999;
276(5):
E990 - E994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. P. Ciaraldi, L. Carter, S. Mudaliar, P. A. Kern, and R. R. Henry
Effects of Tumor Necrosis Factor-{alpha} on Glucose Metabolism in Cultured Human Muscle Cells from Nondiabetic and Type 2 Diabetic Subjects
Endocrinology,
December 1, 1998;
139(12):
4793 - 4800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Park, T. P. Ciaraldi, K. Lindgren, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, S. R. Tufari, J. H. Veerkamp, A. Vidal-Puig, and R. R. Henry
Troglitazone Effects on Gene Expression in Human Skeletal Muscle of Type II Diabetes Involve Up-Regulation of Peroxisome Proliferator-Activated Receptor-{gamma}
J. Clin. Endocrinol. Metab.,
August 1, 1998;
83(8):
2830 - 2835.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. S. Park, T. P. Ciaraldi, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, and R. R. Henry
Troglitazone Regulation of Glucose Metabolism in Human Skeletal Muscle Cultures from Obese Type II Diabetic Subjects
J. Clin. Endocrinol. Metab.,
May 1, 1998;
83(5):
1636 - 1643.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. A. Kern
Potential Role of TNFalpha and Lipoprotein Lipase as Candidate Genes for Obesity
J. Nutr.,
September 1, 1997;
127(9):
1917 - 1917.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Esterbauer, H. Oberkofler, F. Krempler, A. D. Strosberg, and W. Patsch
The Uncoupling Protein-3 Gene Is Transcribed from Tissue-specific Promoters in Humans but Not in Rodents
J. Biol. Chem.,
November 10, 2000;
275(46):
36394 - 36399.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|